VisionSys AI Inc

The company is undergoing a strategic business transformation, now exclusively focused on brain-computer interface (BCI) technologies and related businesses. It has fully divested its prior professional education and STEM education businesses following Divestiture 2024 and Disposition 2025. The BCI business is centered on developing and applying core algorithms, along with related software and hardware systems for brain-computer interaction. Through these capabilities, the company intends to develop, procure, sell, and distribute BCI-enabled or BCI-adjacent products and solutions, and provide related technical services. Its mission is to use intelligent systems to connect technological innovation with practical applications, providing individuals, institutions, and commercial organizations with technology-enabled solutions in healthcare, rehabilitation, general wellness management, and related fields. BCI technology aims to establish communication channels between the brain or nervous system and external devices. BCI systems may collect, process, decode, and translate neural or physiological signals into machine-readable commands or analytical outputs. Potential applications include medical rehabilitation, mobility assistance, communication assistance, neurological monitoring, sensory support, sleep support, attention monitoring, stress relief, meditation, smart device control, human-machine interaction, neuroscience research, assisted living, and other consumer, medical, research, industrial, and professional scenarios. The BCI business is currently at an early stage.